Lexicon Pharmaceuticals
LXRX
#6680
Rank
โ‚ฌ0.72 B
Marketcap
1,62ย โ‚ฌ
Share price
2.25%
Change (1 day)
32.15%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2023 (TTM): -0,64ย โ‚ฌ

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -0,13ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -0,54ย โ‚ฌ an increase over its 2021 EPS that were of -0,54ย โ‚ฌ.

EPS history for Lexicon Pharmaceuticals from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-0,64ย โ‚ฌ17.61%
2022-0,54ย โ‚ฌ-0%
2021-0,54ย โ‚ฌ10.91%
2020-0,49ย โ‚ฌ-145.08%
20191,09ย โ‚ฌ-206.09%
2018-1,03ย โ‚ฌ-5.74%
2017-1,09ย โ‚ฌ-10.95%
2016-1,22ย โ‚ฌ2640%
2015-0,04461ย โ‚ฌ-96.34%
2014-1,22ย โ‚ฌ-2.53%
2013-1,25ย โ‚ฌ-9.09%
2012-1,37ย โ‚ฌ-37.14%
2011-2,19ย โ‚ฌ0%
2010-2,19ย โ‚ฌ-39.66%
2009-3,62ย โ‚ฌ3.57%
2008-3,50ย โ‚ฌ-8.2%
2007-3,81ย โ‚ฌ-24.69%
2006-5,06ย โ‚ฌ42.11%
2005-3,56ย โ‚ฌ-22.97%
2004-4,62ย โ‚ฌ-35.09%
2003-7,12ย โ‚ฌ-0%
2002-7,12ย โ‚ฌ62.86%
2001-4,37ย โ‚ฌ-19.54%
2000-5,43ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
16,94ย โ‚ฌ-12,760.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
5,26ย โ‚ฌ-4,026.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
37,39ย โ‚ฌ-28,040.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-5,21ย โ‚ฌ 3,793.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
8,93ย โ‚ฌ-6,773.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-0,01784ย โ‚ฌ-86.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-0,67ย โ‚ฌ 400.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
0,34ย โ‚ฌ-353.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-26,13ย โ‚ฌ 19,426.67%๐Ÿ‡บ๐Ÿ‡ธ USA